Abstract: Described herein are methods for treating disorders that relate to neurons that express the neurokinin-1 receptor (NK-1R) in a subject which comprises administering to the subject an effective amount of the pharmaceutical composition of the non-cleavable conjugate comprising a molecule that is recognized and internalized by the NK-1R, and a molecule that is taken inside the cell to kill or temporarily alter the cell.
Type:
Grant
Filed:
February 18, 2016
Date of Patent:
December 20, 2022
Assignee:
VEIOVE ANIMAL HEALTH INC.
Inventors:
Douglas A Lappi, Brian J Russell, E Denise Higgins
Abstract: Described herein are methods for treating disorders that relate to neurons that express the neurokinin-1 receptor (NK-1R) in a subject which comprises administering to the subject an effective amount of the pharmaceutical composition of the non-cleavable conjugate comprising a molecule that is recognized and internalized by the NK-1R, and a molecule that is taken inside the cell to kill or temporarily alter the cell.
Type:
Application
Filed:
February 18, 2016
Publication date:
September 21, 2017
Applicant:
Veiove Animal Health
Inventors:
Douglas A. Lappi, Brian J. Russell, E. Denise Higgins